TY  - JOUR
AU  - Santos de Lima, Sarah Kymberly
AU  - Novaes Cavallone, Ítalo
AU  - Serrano López, Dolores Remedios
AU  - Anaya, Brayan J.
AU  - Lalatsa, Aikaterini
AU  - Dalastra Laurenti, Márcia
AU  - Ghilardi Lago, João Henrique
AU  - Da Silva Souza, Dalete Christine
AU  - Pustiglione Marinsek, Gabriela
AU  - Soares Lopes, Beatriz
AU  - De Britto Mari, Renata
AU  - Domingues Passero, Luiz Felipe
PY  - 2023
DO  - 10.3390/pharmaceutics15112602
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/111905
T2  - Pharmaceutics
AB  - Cutaneous leishmaniasis exhibits a wide spectrum of clinical manifestations; however, only a limited number of drugs are available and include Glucantime® and amphotericin B, which induce unacceptable side effects in patients, limiting their use....
LA  - eng
M2  - 1
PB  - MDPI
KW  - Topical treatment
KW  - 8-hydroxyquinoline
KW  - Quinolines
KW  - L. (L.) amazonensis
KW  - Cutaneous leishmaniasis
TI  - Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
TY  - journal article
VL  - 15
ER  -